Doctornow

Doctornow was paid $10.85M by Medicaid between Apr 2021 and Nov 2024, across 9 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 64% of everything it billed.

33Billing provider infoDOCTORNOW
NORTHRIDGE, CA 91324

33aNPI1205410933assigned 05/10/2021

33bProvider typeClinical Medical Laboratory

28Total paid$10.85M

24GClaims184,811

24DCodes billed9

24AFirst – last monthApr 2021 – Nov 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#70 of 561

Median peer was paid$222K

This provider vs. median49×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	29,133	$749K
2022	126,635	$8.72M
2023	23,856	$1.28M
2024incomplete	5,187	$111K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	64%	70,271	31,031	$6.93M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	19%	54,901	23,354	$2.07M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	13%	45,052	20,545	$1.43M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.5%	7,567	3,168	$267K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,348	1,213	$94K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	4,938	1,891	$44K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	699	209	$20K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	18	18	$550.20
99000		<1%	17	14	$14.44

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANVAR, MICHAEL (CEO)

Same official

Other billing entities under ANVAR, MICHAEL

Full network →

Provider	Location	Paid
Doctornow	Los Angeles, CA	$1.40M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.